Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic lupus erythematosus and pregnancy.

R H Derksen1

  • 1Department of Internal Medicine, University Hospital Utrecht, The Netherlands.

Rheumatology International
|January 1, 1991
PubMed
Summary

Pregnancy in women with systemic lupus erythematosus (SLE) may not worsen the disease. However, active SLE or kidney issues at conception increase risks for mothers and fetuses, including fetal death, particularly with antiphospholipid antibodies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus.

Clinical and experimental immunology·2001
Same author

Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces.

British journal of haematology·2001
Same author

Lupus anticoagulant in cardiovascular diseases: the role of beta2-glycoprotein I.

Annals of medicine·2001
Same author

Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes.

Arthritis and rheumatism·2001
Same author

How to treat women with antiphospholipid antibodies in pregnancy?

Annals of the rheumatic diseases·2000
Same author

Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes.

The Journal of biological chemistry·2000

Area of Science:

  • Reproductive Medicine
  • Rheumatology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune disease affecting multiple organs.
  • Pregnancy in women with SLE has historically been associated with poor maternal and fetal outcomes.
  • Previous beliefs suggested pregnancy often exacerbates SLE, but recent data warrant re-evaluation.

Purpose of the Study:

  • To critically analyze existing literature on pregnancy outcomes in women with SLE.
  • To revise the understanding of how pregnancy affects SLE disease activity.
  • To identify key risk factors for adverse maternal and fetal outcomes in pregnant SLE patients.

Main Methods:

  • Systematic review and critical analysis of controlled prospective studies.
  • Evaluation of data on disease activity, renal function, and antibody presence.
  • Assessment of maternal complications, fetal loss, and prematurity rates.

Main Results:

  • The notion that pregnancy exacerbates SLE requires revision based on current evidence.
  • Active SLE or significant renal impairment at conception correlates with increased maternal complications and adverse fetal outcomes (fetal loss, prematurity).
  • Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin) are linked to late-term fetal death, likely via placental thrombosis.

Conclusions:

  • Pregnancy in SLE necessitates comprehensive preconceptional counseling.
  • Close multidisciplinary collaboration among internists, rheumatologists, obstetricians, and neonatologists is crucial.
  • Further research on antithrombotic treatments for antiphospholipid antibodies is needed to guide clinical practice.

Related Experiment Videos